U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201389) titled 'CARE (Chemotherapy Alopecia REduction)' on Sept. 24.
Brief Summary: The goal of this research study is to determine if the DigniCap Scalp Cooling System can help prevent chemotherapy-induced hair loss in Black patients.
Study Start Date: Sept. 24
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Breast - Female
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III
Chemotherapy Induced Alopecia
Intervention:
DEVICE: Scalp Cooling by DigniCap
Scalp cooling with the DigniCap Delta will occur with each chemotherapy dose. The cooling wrap is primed, fitted, and checked for proper contact before a standardized pre-c...